Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Wellgistics Health (WGRX) Receivables - Net (2024 - 2025)

Wellgistics Health filings provide 2 years of Receivables - Net readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 319.18% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 319.18% increase, with the full-year FY2025 number at $1.1 million, up 319.18% from a year prior.
  • Receivables - Net hit $1.1 million in Q4 2025 for Wellgistics Health, up from $1.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.8 million in Q1 2025 to a low of $271298.0 in Q4 2024.